- The company demonstrated its SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console at two international medical conferences in October 2026.
- At the European Association for Cardio-Thoracic Surgery annual meeting in Barcelona, CEO Dr. Sudhir Srivastava performed a robotic-assisted atrial septal defect procedure on a patient approximately 7,500 miles away in Bengaluru, India.
- Four additional robotic telesurgeries were performed or broadcast during the inaugural Society of Robotic Surgery India conference, covering urological, colorectal, pediatric and gynecological procedures.
- The company reported 205 telesurgeries performed with the SSi Mantra system as of October 23, 2026, including cardiac procedures.
- The demonstrations highlight the potential for remote robotic surgery to extend specialist expertise beyond major medical centers, although widespread adoption depends on clinical validation, connectivity and regulatory requirements.
- SS Innovations is pursuing U.S. Food and Drug Administration clearance for the SSi Mantra, with completion of the 510(k) review targeted for the first quarter of 2027; the timeline remains subject to the FDA’s review.
SS Innovations (NASDAQ: SSII), a developer of innovative surgical robotic technologies, showcased its surgical robotics platform in a series of remote operations during October medical conferences in Spain and India, including a robotic-assisted cardiac procedure performed by a surgeon approximately 7,500 miles from the patient (https://nnw.fm/jAH8c).
The demonstrations featured the company’s SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console. At the 40th European Association for Cardio-Thoracic Surgery (“EACTS”) annual meeting in Barcelona, SS Innovations Chairman and Chief Executive Officer Dr. Sudhir Srivastava remotely performed an atrial septal defect procedure on a patient at Sri Madhusudan Sai Institute of Medical Sciences and Research in Bengaluru, India.
Dr. Lalit Malik, chief cardiac surgeon of Manipal Hospital Jaipur, provided patient-side support. The procedure was performed live on stage for conference attendees, demonstrating the system’s ability to transmit a surgeon’s commands over a long distance while enabling the operating team at the patient’s location to provide direct clinical support.
The company’s announcement on October 26 also described four separate telesurgeries performed or broadcast during the inaugural Society of Robotic Surgery (“SRS”) India conference in New Delhi. The New Delhi demonstrations covered a right partial nephrectomy, a right hemicolectomy, a left-sided pyeloplasty on a pediatric patient, and a modified radical hysterectomy with sentinel lymph node biopsy.
The procedures involved different surgical specialties, offering a broader demonstration of the platform’s potential applications than a single-procedure showcase. The conference was organized by the Society of Robotic Surgery and officially inaugurated by India’s Minister of Science and Technology, Dr. Jitendra Singh.
“We were grateful for the opportunity to demonstrate the advanced telesurgery capabilities of our SSi Mantra surgical robotic system and SSi MantrAsana tele-surgeon console this month at the 40th EACTS Annual Meeting in Barcelona and the inaugural SRS India Conference in New Delhi,” Dr. Srivastava said. “As a pioneer and leader in telesurgery technology, SS Innovations aims to dismantle traditional geographic barriers and democratize access to world class health care.”
Taken together, the two events brought the technology before audiences in cardiothoracic surgery and the wider robotic surgery community. The demonstrations also underscored the company’s effort to position telesurgery as an extension of its existing surgical robotics business. As of October 23, SS Innovations reported that 205 telesurgeries, including complex cardiac procedures, had been performed using the SSi Mantra system.
The SSi MantrAsana is a portable tele-surgeon console designed to provide control functionality comparable to the standard surgeon command center while supporting remote procedures. The company says its architecture combines ultra-low-latency connectivity with high-definition visualization and precise instrument control.
Latency is a central technical consideration in telesurgery. Delays between a surgeon’s movements and the robotic system’s response can affect the precision of an operation. Reliable connections and appropriate clinical protocols are therefore essential, particularly when a surgeon and patient are separated by thousands of miles.
The SSi Mantra itself is a modular robotic platform designed for a range of procedures. Its configuration can include three to five robotic arms, a surgeon command center with a 3D 4K display, and instruments intended for different surgical specialties. The system also supports instruments designed for pediatric and ear, nose and throat procedures.
Its modular architecture is intended to accommodate a variety of operating-room requirements. The company has reported clinical validation in India across more than 190 types of surgical procedures.
SS Innovations’ commercial proposition combines this broad procedural capability with an emphasis on making robotic surgery more affordable and accessible. Price can influence adoption, particularly in healthcare markets where hospitals face constraints on capital spending. However, the ability to demonstrate reliable performance and meet local regulatory requirements remains essential to broader deployment.
SS Innovations is also pursuing entry into the U.S. market. The company has submitted a response to an FDA request for additional information concerning its 510(k) submission for the SSi Mantra system. The response included final data from an expanded human clinical validation study, according to the company’s update. SS Innovations is targeting completion of the FDA review in the first quarter of 2027. The company is also working toward CE marking to support broader access to European markets.
For more information, visit the company’s website at www.SSInnovations.com.
NOTE TO INVESTORS: The latest news and updates relating to SSII are available in the company’s newsroom at https://nnw.fm/SSII
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a specialized communications platform with a focus on financial news and content distribution for private and public companies and the investment community. It is one of 75+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled recognition and brand awareness. NNW is where breaking news, insightful content and actionable information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.NetworkNewsWire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: https://www.NetworkNewsWire.com/Disclaimer
NetworkNewsWire
Austin, Texas
www.NetworkNewsWire.com
512.354.7000 Office
[email protected]
NetworkNewsWire is powered by IBN
